![Gastrointestinal Dystonia in Severe Neurodisabilities- Andrew Barclay](https://bspghan.org.uk/wp-content/uploads/2021/06/GI-Dystonia-1080x675.png)
Gastrointestinal Dystonia in Severe Neurodisabilities- Andrew Barclay
This page is restricted to BSPGHAN members.
Please login.
This page is restricted to BSPGHAN members.
Please login.
Dear Members
IBD UK will be sharing this open letter to Matt Hancock on the IBD UK website and Crohn’s & Colitis UK website on Monday morning. We will then be sharing it on social media channels with the attached graphic and copy below, which you are welcome to use in your own posts if you are planning on sharing the letter.
Twitter:
The @IBDUKTEAM report showed that IBD care across the UK needs to change. IBD needs to be taken seriously, so we’re asking @MattHancock for a clear government strategy for improvement. Please RT and support our ask for #BetterIBDCare https://ibduk.org/blog/2021/our-open-letter-to-matt-hancock
Facebook:
The IBD UK report showed that IBD care across the UK needs to change. IBD needs to be taken seriously, so we’re asking @matthancockofficial for a clear government strategy for improvement. Please share and support our ask for #BetterIBDCare https://ibduk.org/blog/2021/our-open-letter-to-matt-hancock
Best wishes.
Jackie
IBD UK
Crohn’s and Colitis UK acting as Secretariat to IBD UK
Tel No: 01727 734471
Email: info@ibduk.org
Follow us on Twitter: @IBDUKTEAM
Today, April 7th, 2021, the Joint Committee on Vaccination and Immunisation (JCVI) has changed their clinical advice on Covid 19 vaccines for those aged under 30 years.
Adults aged 18 to 29 who do not have an underlying health condition that puts them at greater risk from Covid should be offered an alternative to the Astra Zeneca vaccine if one is available.
The MHRA advised that-
The Pfizer/BioNTech vaccine is authorised for use in individuals aged 16 years and over, and the Oxford/AstraZeneca vaccine is authorised for individuals aged 18 years and over.
Also see that here that the RCPCH updated their advice on 29th March 2021, for paediatricians on children and young people and the COVID-19 vaccination programme https://www.rcpch.ac.uk/news-events/news/message-paediatricians-children-young-people-covid-19-vaccination-programme
This advice may be updated in light of the announcement today.
We are now in the first phase of the programme during which young people (aged 16 years and over) with specific clinical vulnerabilities will be offered vaccination.1 ( Based on JCVI advice, individuals aged 16–65 years in at-risk groups are eligible for immunisation in Phase 1 of the programme).
The Green Book says: “Children and young people have a very low risk of COVID-19, severe disease or death due to SARS-CoV-2 compared to adults and so COVID-19 vaccines are not routinely recommended for children and young people under 16 years of age. Children under 16 year of age, even if they are CEV, are at low risk of serious morbidity and mortality, and, given the absence of safety and efficacy data on the vaccine, are not recommended for vaccination.” 2
While this is the case, vaccinations should not be offered to children and young people who fall outside the categories advised by the JCVI and the Green Book.
The only other group identified by the Joint Committee on Vaccination and Immunisation (JCVI) and the Green Book3 that may be considered for the vaccine during phase 1 are:
Such vaccinations would be considered unlicensed use.4 Paediatricians should discuss the benefits and risks and limited safety data with children, young people and their parents/guardians. Any vaccination would need to be authorised by a prescriber (usually a doctor). We would expect that this discussion would take into account:
It is important to stress that at this time the JCVI consider that there are no data to support use of the vaccine in younger age groups or other clinical groups.
Sue Protheroe
BSPGHAN President April 7th 2021
Dear members
I hope this email finds you all well.
I trust that you are looking forward to our BSPGHAN Annual Meeting 27-29th April. If you already registered for January, there's no need to re-register for April. A reminder that accepted abstracts will be published in Frontline Gastroenterology.
I hope that you are making regular use of your access to the journal and enjoying the brilliant educational material that is accessed via our members login page?
Please see Highlights for Members – Publishing Papers to Impact on Practice for March 2021 sent from the Editor in Chief, Professor Mark Beattie.
Best wishes
Sue BSPGHAN President.
Dear Colleagues
I wanted to highlight some of our recent published content that I thought would be of interest
The gut microbiome: what every gastroenterologist needs to know
https://fg.bmj.com/content/12/2/118
Getting to grips with sarcopenia: recent advances and practical management for the gastroenterologist
https://fg.bmj.com/content/12/1/53
Diagnostic ileocolonoscopy: getting the basics right
https://fg.bmj.com/content/11/6/484
Refeeding syndrome : physiological background and practical management
https://fg.bmj.com/content/11/5/404
British Society of Gastroenterology (BSG)-led multisociety consensus care bundle for the early clinical management of acute upper gastrointestinal bleeding
https://fg.bmj.com/content/11/4/311
Also online first
How to manage a high-output stoma
https://fg.bmj.com/content/early/2021/03/22/flgastro-2018-101108
Short bowel syndrome in infancy: recent advances and practical management
https://fg.bmj.com/content/early/2020/12/16/flgastro-2020-101457
Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
https://fg.bmj.com/content/early/2020/11/22/flgastro-2020-101679
Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience
https://fg.bmj.com/content/early/2020/10/26/flgastro-2020-101598
Eosinophilic oesophagitis: recent advances and practical management
https://fg.bmj.com/content/early/2020/09/06/flgastro-2019-101313
Check out the journal – lots of other excellent content across gastroenterology, endoscopy, hepatology and nutrition
Follow us on twitter https://twitter.com/FrontGastro_BMJ
Check out the blog https://blogs.bmj.com/fg/
Listen to our regular podcasts https://soundcloud.com/bmjpodcasts/sets/frontline-gastroenterology
Check out the instructions for authors – send us your best work – pre submission enquiries welcome https://fg.bmj.com/pages/authors/
Mark Beattie
Professor RM Beattie
Consultant Paediatric Gastroenterologist
Honorary Professor of Paediatric Gastroenterology and Nutrition
Editor in Chief Frontline Gastroenterology
Contact Us l Privacy Policy l Members Login
© 2021 British Society of Paediatric Gastroenterology, Hepatology and Nutrition l Charity Number 299294 l VAT registration number 323665308